Eyelid Margin Health Series

1. Understanding Demodex Blepharitis & Meibomian Gland Dysfunction

Welcome to episode 1 of the Eyelid Margin Health Series, presented by The Fundingsland Group (TFG) in collaboration with Media MICE and the Intrepid Eye Society. 

In this episode, Drs. Selina McGee and Mark Schaeffer (United States) discuss the critical impact of Demodex blepharitis and meibomian gland dysfunction (MGD) on patient outcomes. They dive into how to evaluate the eyelid, how these conditions affect vision, and how to manage eyelid health successfully.

2. Diagnosis of Demodex Blepharitis & Meibomian Gland Dysfunction

In episode 2 of the Eyelid Margin Health Series, brought to you in collaboration with The Fundingsland Group (TFG), join optometrists Selina McGee and Mark Schaeffer (United States) from the Intrepid Eye Society, as they walk through the essential steps for screening and diagnosing early-stage Demodex blepharitis and meibomian gland dysfunction (MGD). 

They cover everything from identifying key indicators during eyelid exams to using advanced diagnostic tools, such as meibography. The episode also dives into effective communication strategies tailored to different patient archetypes, helping eye care professionals to build stronger connections with patients. And keep a look out as Drs. McGee and Schaeffer share survey results from the Intrepid Eye Society to offer valuable insights into best practices.

These videos complement the Consensus Statement, published in the COOKIE supplement. Visit TFG (https://www.youtube.com/watch?v=lJKD_-hdAig&list=PLMCjXiuNMDgL696svEtZjgb6E8TLqobKM&index=4)  to learn more about this COPE-approved course. 

This activity is supported by unrestricted educational grants from Johnson & Johnson Vision, Sight Sciences, and Tarsus Pharmaceuticals, Inc.